Found: 7
Select item for more details and to access through your institution.
Candidate therapeutic agents in a newly established triple wild‐type mucosal melanoma cell line.
- Published in:
- Cancer Communications, 2022, v. 42, n. 7, p. 627, doi. 10.1002/cac2.12315
- By:
- Publication type:
- Article
Neutrophil extracellular traps promote invasion and metastasis via NLRP3-mediated oral squamous cell carcinoma pyroptosis inhibition.
- Published in:
- Cell Death Discovery, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41420-024-01982-9
- By:
- Publication type:
- Article
The efficacy and safety of dalpiciclib, a cyclin-dependent kinase 4/6 inhibitor, in patients with advanced head and neck mucosal melanoma harboring CDK4 amplification.
- Published in:
- BMC Medicine, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12916-024-03431-x
- By:
- Publication type:
- Article
Pharmacogenomic landscape of head and neck squamous cell carcinoma informs precision oncology therapy.
- Published in:
- Science Translational Medicine, 2022, v. 14, n. 661, p. 1, doi. 10.1126/scitranslmed.abo5987
- By:
- Publication type:
- Article
Palbociclib-based high-throughput combination drug screening identifies synergistic therapeutic options in HPV-negative head and neck squamous cell carcinoma.
- Published in:
- BMC Medicine, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12916-022-02373-6
- By:
- Publication type:
- Article
Palbociclib-based high-throughput combination drug screening identifies synergistic therapeutic options in HPV-negative head and neck squamous cell carcinoma.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Apatinib potentiates the therapeutic effect of anti‐PD‐1 in locally advanced head and neck cancers.
- Published in:
- Oral Diseases, 2024, v. 30, n. 5, p. 2940, doi. 10.1111/odi.14768
- By:
- Publication type:
- Article